Beyond Palliation: Economic Feasibility of Integrating Cancer-Directed Therapy Into Home-Based Palliative Care, a Retrospective Cohort Study in Rural Uganda
This retrospective cohort study in rural Uganda demonstrates that integrating cancer-directed treatment into home-based palliative care is cost-neutral compared to palliation alone, as the lower daily costs and reduced visit frequency associated with effective treatment offset the higher total program costs and longer enrollment duration.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In many parts of the world, a cancer diagnosis often leads to a difficult choice. While modern medicine can cure or control many types of cancer, the path to treatment is frequently blocked by distance, cost, and a lack of local specialists. In these situations, patients often turn to palliative care, a form of medical support focused on relieving pain, managing symptoms, and providing emotional comfort. For decades, the prevailing assumption in low-resource settings has been that palliative care and curative treatment are separate paths. The logic was simple: if a patient cannot reach a hospital for chemotherapy or surgery, the best a local team can do is make them comfortable. It was widely believed that trying to bridge the gap to get patients to a hospital for treatment would drain the limited funds of a palliative care program, making it impossible to help as many people as possible.
This assumption, however, overlooks a crucial reality: when a disease is left untreated, it often becomes harder and more expensive to manage over time. A team of researchers from the Icahn School of Medicine at Mount Sinai and the Rays of Hope Hospice in Jinja, Uganda, set out to test whether this old belief held true. They asked a straightforward question: Is it actually more expensive to help a patient get cancer treatment while also providing comfort care, or does the treatment itself save money in the long run by stopping the disease from getting worse? Their investigation focused on a specific group of women in rural Uganda, comparing those who received only symptom management against those who received symptom management plus help getting to a cancer center for treatment.
The researchers looked back at the records of 76 women with breast or cervical cancer who were cared for by the Rays of Hope Hospice between 2019 and 2021. This hospice operates in a rural region where patients live far from major cities. The team divided the women into two groups based on the care they received. One group, consisting of 43 women, received palliative care alone. The other group, with 33 women, received the same palliative care but also had the hospice team arrange their transportation, lodging, and appointments at the Uganda Cancer Institute to receive chemotherapy or other cancer-directed therapies. The researchers calculated the total cost to the hospice program for each woman, including the wages of the staff who drove to their homes, the fuel for the vehicles, and the cost of any medical supplies or food assistance provided.
The results challenged the idea that adding treatment support would bankrupt a program. When the researchers tallied the total cost for each patient over the entire time they were in the program, the two groups were surprisingly similar. The women who received only palliative care cost the program a median of $2,156 each. The women who received palliative care plus facilitated treatment cost a median of $2,952 each. While the second group cost slightly more in total, the difference was not statistically significant, meaning the extra expense was not a major financial burden.
The story changes, however, when you look at how long the women stayed in the program and how often the hospice team had to visit them. The women who received cancer treatment stayed in the program for much longer—about 401 days on average, compared to just 119 days for those who did not receive treatment. Because the treatment group stayed in care for so much longer, the cost per day was drastically lower. For the women receiving only palliative care, the program spent about $20.95 per day for each patient. For the women receiving treatment, the daily cost was only $8.00.
This difference happened because the women who received cancer treatment did not need as many visits. The hospice team visited the women receiving only palliative care about 1.3 times a month. In contrast, the women receiving cancer treatment were visited only 0.5 times a month. The treatment appeared to slow the progression of the disease, reducing the severity of symptoms and the need for constant intervention. The most expensive part of the hospice's work was not the medicine or the food, but the travel. Staff had to drive long distances to reach patients in remote villages, and the wages for the time spent driving made up nearly 99% of the total cost. Because the women receiving treatment were healthier and required fewer trips, the program spent far less on travel and labor per day.
The study suggests that for a palliative care program in a low-resource setting, helping a patient access cancer treatment is not a financial drain, but rather a way to make the program more efficient. By treating the underlying disease, the need for frequent, costly home visits decreases, allowing the program to support patients for longer periods without increasing the overall budget. The researchers noted that the women in the treatment group were, on average, younger than those in the palliative-only group, which may have influenced their ability to receive treatment, but the core finding remained: integrating treatment with palliative care did not significantly raise costs.
These findings offer a new perspective on how healthcare resources can be used in places where money is scarce. Instead of viewing palliative care and curative treatment as competing priorities, the data suggests they can work together. By coordinating access to cancer therapy, a palliative care program can reduce the daily burden of disease, keep patients out of the hospital, and stretch their limited funds further. The study does not claim that this model works everywhere or that it solves every problem, but it provides strong evidence that the fear of high costs should not stop programs from helping patients get the treatment they need. In the rural communities of Uganda, and potentially in similar settings around the world, the most effective way to care for a patient may be to treat the cancer, not just the pain.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.